The WHO reports global circulation of fraudulent medical products. Between 2013 and 2017, 1,500 medical products worldwide were found to be fake or substandard, according to the World Health Organization (WHO). Antibiotics and antimalaria drugs are among the most susceptible to fraud, as well as anesthetics, cancer drugs, vaccines, contraceptives, and heart and diabetes medicines. Both innovative patented and generic drugs are targets. In 2013, the WHO launched the Global Surveillance and Monitoring System to help countries detect and report substandard products. As of November 2017, the WHO has issued 20 global medical product alerts, conducted 17 training workshops, and trained more than 400 regulatory personnel in 126 member states to reduce fraud. The WHO's goal is to prevent the manufacture, sale, and consumption of fake products, detect substandard products in supply chains, and respond quickly to incidents of fraud. Read the report at http://www.who.int/medicines/regulation/ssffc/publications/gsms-report-sf/en.